Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D02AC	VASELINE PURE	G	Vaseline pure - 20g	20g	Ointment	103,668 L.L
B01AF01	VAROXA	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
G04BE08	VIVIDA 20	G	Tadalafil - 20mg	20mg	Tablet, film coated	1,721,398 L.L
G04BE08	VIVIDA 20	G	Tadalafil - 20mg	20mg	Tablet, film coated	624,567 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	954,128 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	954,128 L.L
C10AA01	VASCOR	G	Simvastatin - 20mg	20mg	Tablet, scored	284,127 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	1,169,143 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	717,612 L.L
J05AF07	VIREAD	B	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	15,716,313 L.L
N07CA01	VASOSERC BID	G	Betahistine dihydrochloride - 24mg	24mg	Tablet	840,861 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 24mg	24mg	Tablet, scored	921,492 L.L
B01AB11	VESSEL DUE F TAB.	B	Sulodexide - 250LRU	250LSU	Capsule, soft gelatin	2,792,505 L.L
A04AA05	VONAXI	G	Palonosetron HCl - 250mcg/5ml	250mcg/5ml	Injectable solution	1,490,321 L.L
A10BH04	VIPIDIA	B	Alogliptin benzoate - 25mg	25mg	Tablet, film coated	2,998,113 L.L
J05AF13	VEMLIDY	B	Tenofovir alafenamide fumarate - 25mg	25mg	Tablet, film coated	26,997,299 L.L
J07BC02	VAQTA	B	Hepatitis A, inactivated, whole virus - 25U/0.5ml	25U/0.5ml	Injectable suspension	2,539,862 L.L
G03DB08	VISANNE	B	Dienogest - 2mg	2mg	Tablet	4,980,280 L.L
L01XG01	VELCADE	B	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	23,616,000 L.L
L01XG01	VELZOME	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	18,154,041 L.L
N03AX12	VOLAR	G	Gabapentin - 300mg	300mg	Capsule	1,100,607 L.L
C09CA03	VIOSTAN 320	G	Valsartan - 320mg	320mg	Tablet, film coated	1,338,467 L.L
C01EB15	VASTAREL	B	Trimetazidine - 35mg	35mg	Tablet, film coated, modified release	1,053,573 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 37.5mg	37.5mg	Capsule, prolonged release	538,881 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	383,955 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	575,933 L.L
L01EX03	VOTRIENT	B	Pazopanib HCl - 400mg	400mg	Tablet, film coated	66,323,011 L.L
J05AB01	VICLORIX 400	G	Aciclovir - 400mg	400mg	Tablet	3,589,851 L.L
L01FE02	VECTIBIX	BioTech	Panitumumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	L.L
L01FE02	VECTIBIX	BioTech	Panitumumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	147,763,999 L.L